SCHEMBL13129751

SCHEMBL13129751

CCC(=O)C(C)(C)C(COC)n1c(=O)[nH]c2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.47
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ CYP1A2 P05177 1/20 0.41
▸ DAO P14920 1/20 0.38
▸ B3GNT2 Q9NY97 3/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ MDM2 Q00987 1/20 0.35
▸ HSD11B1 P28845 2/20 0.35
▸ CHRM2 P08172 1/20 0.35
▸ CHRM4 P08173 1/20 0.35
▸ CHRM5 P08912 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ RAB9A P51151 1/20 0.34
▸ GRIA1 P42261 1/20 0.34
▸ GRIA2 P42262 1/20 0.34
▸ GRIA3 P42263 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2309299 0.87 POLB (0.48) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL2314575 0.72 POLB (0.50) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL14665153 0.70 POLB (0.54) POLBMEN1KMT2AALDH1A1CYP1A2
SCHEMBL640651 0.69 POLB (0.59) POLBMEN1KMT2AALDH1A1CYP1A2
SCHEMBL2312582 0.68 POLB (0.48) POLBMEN1KMT2AALDH1A1CYP1A2
SCHEMBL2312588 0.68 POLB (0.48) POLBMEN1KMT2AALDH1A1CYP1A2
SCHEMBL14622076 0.68 POLB (0.67) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL10834778 0.68 POLB (0.57) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL14664128 0.68 POLB (0.54) POLBMEN1KMT2AALDH1A1CYP1A2
SCHEMBL2308145 0.68 POLB (0.57) POLBMEN1KMT2AALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150556-B2 Benzimidazolone chymase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-06 — — US disclosed
US-9150556-B2 Benzimidazolone chymase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-06 — — US disclosed
US-20100240702-A1 Benzimidazolone Chymase Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 — — US disclosed
US-20100240702-A1 Benzimidazolone Chymase Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240702-A1 Benzimidazolone Chymase Inhibitors CMA1, SERPINB1, CPA3 POLB 3716/4885MEN1 1035/4885KMT2A 4203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback